Buy Rating Reaffirmed on Inhibrx Ahead of Key INBRX-106 Phase 2 Readout; $230 Price Target Maintained
at www.tipranks.com (Fri, 14-Aug 1:15 PM)
Stifel Nicolaus Remains a Buy on Inhibrx Biosciences Inc (INBX)
at www.tipranks.com (Fri, 14-Aug 10:05 AM)
Inhibrx Biosciences GAAP EPS of -$2.34 beats by $0.05
at seekingalpha.com (Thu, 13-Aug 4:42 PM)
